159 related articles for article (PubMed ID: 1847765)
1. The cytochrome P450 metabolic pathway of arachidonic acid in the cornea.
Schwartzman ML; Davis KL; Nishimura M; Abraham NG; Murphy RC
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():185-92. PubMed ID: 1847765
[No Abstract] [Full Text] [Related]
2. Corneal arachidonate metabolism via cytochrome P450: characterization of two novel biologically active metabolites.
Masferrer JL; Murphy RC; Abraham NG; Laniado-Schwartzman M
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():351-4. PubMed ID: 2546388
[No Abstract] [Full Text] [Related]
3. Modification of arachidonic acid metabolism via the cytochrome P450-related monooxygenase system.
Schwartzman ML
Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():241-9. PubMed ID: 2169180
[No Abstract] [Full Text] [Related]
4. Cytochrome P450-dependent arachidonate metabolites, renal function and blood pressure regulation.
McGiff JC; Carroll MA
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():675-82. PubMed ID: 1847570
[No Abstract] [Full Text] [Related]
5. Cytochrome P450-dependent arachidonate metabolism in corneal epithelium: formation of biologically active compounds.
Schwartzman ML; Abraham NG; Masferrer J; Dunn MW; McGiff JC
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():78-83. PubMed ID: 2821771
[No Abstract] [Full Text] [Related]
6. Brain synthesis and cerebrovascular action of cytochrome P-450/monooxygenase metabolites of arachidonic acid.
Ellis EF; Amruthesh SC; Police RJ; Yancey LM
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():201-4. PubMed ID: 1825540
[No Abstract] [Full Text] [Related]
7. Ion transport inhibition in the medullary thick ascending limb of Henle's loop by cytochrome P450-arachidonic acid metabolites.
Escalante B; Erlij D; Falck JR; McGiff JC
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():209-12. PubMed ID: 1847767
[No Abstract] [Full Text] [Related]
8. Effect of metabolic inhibitors on arachidonic acid metabolism in the corneal epithelium: evidence for cytochrome P450-mediated reactions.
Stoltz RA; Conners MS; Dunn MW; Schwartzman ML
J Ocul Pharmacol; 1994; 10(1):307-17. PubMed ID: 8207335
[TBL] [Abstract][Full Text] [Related]
9. 12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea.
Schwartzman ML; Balazy M; Masferrer J; Abraham NG; McGiff JC; Murphy RC
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8125-9. PubMed ID: 2825178
[TBL] [Abstract][Full Text] [Related]
10. Role of epoxygenase metabolites of arachidonic acid in intracellular signal transduction.
Hirai A; Yoshida S; Nishimura M; Seki K; Tamura Y; Yoshida S
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():827-30. PubMed ID: 1825419
[No Abstract] [Full Text] [Related]
11. Biosynthesis of P450 products of arachidonic acid in humans: increased formation in cardiovascular disease.
Catella F; Lawson J; Braden G; Fitzgerald DJ; Shipp E; FitzGerald GA
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():193-6. PubMed ID: 1705382
[No Abstract] [Full Text] [Related]
12. Regulation of renal Na-K-ATPase by eicosanoids: central role of the cytochrome P450-monooxygenase pathway.
Satoh T; Cohen HT; Katz AI
Trans Assoc Am Physicians; 1992; 105():86-92. PubMed ID: 1339239
[No Abstract] [Full Text] [Related]
13. An epoxygenase metabolite of arachidonic acid 5,6 epoxy-eicosatrienoic acid mediates angiotensin-induced natriuresis in proximal tubular epithelium.
Romero MF; Madhun ZT; Hopfer U; Douglas JG
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():205-8. PubMed ID: 1847766
[TBL] [Abstract][Full Text] [Related]
14. Ocular effects of a novel cytochrome P-450-dependent arachidonic acid metabolite.
Masferrer JL; Murphy RC; Pagano PJ; Dunn MW; Laniado-Schwartzman M
Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):454-60. PubMed ID: 2466808
[TBL] [Abstract][Full Text] [Related]
15. 12(R)-hydroxyeicosatrienoic acid: a vasodilator cytochrome P-450-dependent arachidonate metabolite from the bovine corneal epithelium.
Murphy RC; Falck JR; Lumin S; Yadagiri P; Zirrolli JA; Balazy M; Masferrer JL; Abraham NG; Schwartzman ML
J Biol Chem; 1988 Nov; 263(32):17197-202. PubMed ID: 3141417
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P-450 metabolites of arachidonic acid: implications for blood pressure regulation.
Carroll MA; Escalante B; McGiff JC
Pol J Pharmacol Pharm; 1990; 42(3):191-201. PubMed ID: 2124686
[TBL] [Abstract][Full Text] [Related]
17. Formation of cytochrome P450 metabolites of arachidonic acid by human placenta.
Schäfer W; Werner K; Schweer H; Schneider J; Zahradnik HP
Adv Exp Med Biol; 1997; 433():411-3. PubMed ID: 9561183
[No Abstract] [Full Text] [Related]
18. Oxygenation of 5,8,11-eicosatrienoic acid by prostaglandin endoperoxide synthase and by cytochrome P450 monooxygenase: structure and mechanism of formation of major metabolites.
Oliw EH; Hörnsten L; Sprecher H; Hamberg M
Arch Biochem Biophys; 1993 Sep; 305(2):288-97. PubMed ID: 8373167
[TBL] [Abstract][Full Text] [Related]
19. Peptide stimulation of cytochrome P-450-related arachidonate metabolism in renomedullary cells: formation of Na+ -K+ ATPase inhibitor.
Carroll MA; McGiff JC; Ferreri NR; Ibraham NG; Songu-Mize E; Schwartzman M
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():427-30. PubMed ID: 3004146
[No Abstract] [Full Text] [Related]
20. Inhibition of renal, cardiac and corneal (Na(+)-K+)ATPase by 12(R)-hydroxyeicosatetraenoic acid.
Masferrer JL; Rios AP; Schwartzman ML
Biochem Pharmacol; 1990 Jun; 39(12):1971-4. PubMed ID: 2162173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
